Axon Therapies raises $32M in an oversubscribed Series A round led by Earlybird Venture Capital and Santé Ventures to advance its novel heart failure treatment.
Amount Raised
$32 Million
Round Type
Series A
San DiegoBiotechnologyInvestors
Description
Axon Therapies announced the close of a $32 million Series A financing, co-led by Earlybird Venture Capital and Santé Ventures. The funding will accelerate clinical trials for a minimally invasive therapy targeting heart failure. Newly appointed CEO Zoar Engelman, PhD, emphasizes the need for effective treatment options. The financing enables the next phase of pivotal studies for their innovative approach.
Quick answer
Axon Therapeutics raised $32 Million in a Series A round, dated September 26, 2025. Investors: Deerfield Management, Cd Capital, KOFA Healthcare, Earlybird Venture Capital and Santé Ventures. Axon Therapeutics is based in San Diego, California, United States.
- How much did Axon Therapeutics raise?
- Axon Therapeutics raised $32 Million in a Series A round on September 26, 2025.
- Who invested in Axon Therapeutics?
- Deerfield Management, Cd Capital, KOFA Healthcare, Earlybird Venture Capital and Santé Ventures are named as investors in this round.
- What does Axon Therapeutics do?
- Axon Therapies is a private MedTech company developing minimally invasive therapies that address the root causes of heart failure.
- Where is Axon Therapeutics based and how big is it?
- Axon Therapeutics is based in San Diego, California, United States.
- Who are the decision-makers at Axon Therapeutics?
- Fundz holds 1 contact at Axon Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Axon Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Reimagine Care raised $2.4M on November 10, 2025.
- Iambic Therapeutics raised $100M (Funding Round) on November 10, 2025.
- GenSight Biologics raised $2.3M (Funding Round) on November 10, 2025.
- Evidium raised $22M (Series A) on November 10, 2025.
- Cornerstone Robotics raised $200M (Funding Round) on November 10, 2025.
- SiteLabs raised $2M (Seed) on November 7, 2025.
Who to call at Axon Therapeutics, and when
A new round usually means Axon Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Axon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Axon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Axon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Axon Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAxon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.